Cyclohexanecarboxylic acid, 3-hydroxy-
- CAS NO.：606488-94-2
- Empirical Formula: C7H12O3
- Molecular Weight: 144.17
- MDL number: MFCD19228828
- SAFETY DATA SHEET (SDS)
- Update Date: 2025-07-24 18:13:52
Properties of Cyclohexanecarboxylic acid, 3-hydroxy-
| Melting point: | 130-132 °C(Solv: ethyl ether (60-29-7)) |
| Boiling point: | 307.9±35.0 °C(Predicted) |
| Density | 1.246±0.06 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Room Temperature |
| form | powder to crystal |
| pka | 4.71±0.13(Predicted) |
| color | White to Almost white |
Safety information for Cyclohexanecarboxylic acid, 3-hydroxy-
Computed Descriptors for Cyclohexanecarboxylic acid, 3-hydroxy-
New Products
Methyl N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-N-nitroso-L-valinate Levofloxacin - Impurity B/ Levofloxacin Related Compound A Ivabradine R isomer Escitalopram - Impurity K Escitalopram Cyno dilol Impurity Paroxetine EP impurity I/Paroxetine Anhydrous EP Impurity I 2-Amino-5-Bromo-6-Chloropyridine 3-Amino-5-bromopicolinic acid 1-(7,8-Dinitro-4,5-dihydro-1H-1,5-methanobenzo[d]azepin-3(2H)-yl)-2,2,2-trifluoroethanone 2-Amino-3-Bromo-5-Cyanopyridine 2-Amino-3-Chloropyridine 2,5-Dibromo-3-MethylpyridineYou may like
-
606488-94-2 3-hydroxycyclohexanecarboxylic acid 98%View Details
606488-94-2 -
3-Hydroxycyclohexanecarboxylic Acid (cis- and trans- mixture) CAS 606488-94-2View Details
606488-94-2 -
17471-10-2 Diphenhydramine EP impurity-A /Diphenhydramine Related Compound A NLT 95%View Details
17471-10-2 -
Dorzolamide Related Compound B/Dorzolamide EP Impurity B NLT 95%View Details
120279-90-5 -
76824-16-3 Famotidine - Impurity D NLT 95%View Details
76824-16-3 -
118-23-0 NLT 95%View Details
118-23-0 -
2407630-84-4 NLT 95%View Details
2407630-84-4 -
573704-41-3 NLT 95%View Details
573704-41-3
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.